Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Shawbrook reassures "no lending exposure" to Blue Motor

Wed, 06th May 2026 14:25

Shawbrook Group PLC - Essex, England-based digital banking platform - Says it has "no lending exposure" to Blue Motor Finance Ltd, as their forward flow purchase agreement, under which Shawbrook acquired loan assets originated by BMF, was not renewed in February. Furthermore, Shawbrook reiterates that it still "considers its exposure to be immaterial" regarding the UK Financial Conduct Authority's proposed GBP9 billion motor finance redress scheme.

Shawbrook's reassurance follows Sky News' report on Tuesday that Blue is "teetering on the brink of collapse" and "lining up administrators as it scrambles to secure a rescue deal." Blue's redress bill looks set to exceed GBP50 million, Sky says. The outlet also noted that Shawbrook had cancelled the above-mentioned funding agreement with Blue, citing "insiders" from the motor finance industry.

Shawbrook current stock price: 321.00 pence, up 2.1% on Wednesday afternoon in London

12-month change: down 19%

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Small Cap Corporate News Finance and Instruments Banking Shawbrook Group

Shares in this article

Related News

IN BRIEF: Brave Bison celebrates multi-year Omnicom contract
1 hour ago

IN BRIEF: Brave Bison celebrates multi-year Omnicom contract

Brave Bison Group PLC - London-based advertising and communications agency - Announces that marketing skills and training platform MiniMBA, which it a...

Novo Nordisk weight-loss pill powers profit beat in race to catch Eli Lilly
2 hours ago

Novo Nordisk weight-loss pill powers profit beat in race to catch Eli Lilly

* Novo nudges up full-year guidance ​after sales, profit beats

Corporate News Eli Lilly + 1 more share
Smith+Nephew first-quarter misses expectations as knee implants falter
2 hours ago

Smith+Nephew first-quarter misses expectations as knee implants falter

* First-quarter underlying sales ​growth 3.1% versus expectations of 3.2%